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ABSTRACT
OBJECTIVE: To assess factors associated with the establishment of permanent 
vascular access for patients with end-stage renal disease.
METHODS: Cross-sectional study conducted in a nationally representative 
sample of Brazilian end-stage renal disease patients in dialysis and transplant 
centers during 2007. The sample comprised only patients who received 
hemodialysis as a primary therapy modality and reported the type of vascular 
access for their primary hemodialysis treatment (N=2,276). Data were from 
the TRS Project – “Economic and Epidemiologic Evaluation of Modalities of 
Renal Replacement Therapy in Brazil”. Multiple logistic regression analysis 
was used to assess factors associated with the establishment of permanent 
vascular access in these patients.
RESULTS: About 30% of the patients studied had an arteriovenous vascular 
access. The following factors were associated with a lower likelihood of 
having an arteriovenous vascular access as a primary type of access: time of 
hemodialysis start since the diagnosis of chronic renal failure ≤ 1 year; shorter 
dialysis therapy; having no private health insurance; living in the central-
western, northeastern and southeastern regions of Brazil; and living in the 
northern region plus having no private health insurance. In the fi nal model 
there was found a positive association between the outcome and pre-dialysis 
care and no were association with socioeconomic and comorbidity variables.
CONCLUSIONS: The study results showed that the focus should on pre-
dialysis care to increase the establishment of an arteriovenous vascular access 
before starting hemodialysis in Brazil.
DESCRIPTORS: Arteriovenous Fistula. Health Services Accessibility. 
Renal Dialysis, instrumentation. Renal Insuffi ciency, Chronic. Cross-
Sectional Studies.
Artigos Originais
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The establishment of an arteriovenous vascular access 
before hemodialysis is the ideal option to treat patients 
with end-stage renal disease (ESRD)5 as it is associ-
ated with better metabolic control and more favorable 
clinical outcomes.8 The vascular access should be 
created in patients within three to six months of an 
anticipated need for dialysisa and it has been considered 
an adequate pre-dialysis care measure.8,14 A permanent 
vascular access for hemodialysis (HD) includes an 
autologous arteriovenous fi stula (AVF) or alternatively 
an arteriovenous graft when suitable veins are not 
available.3,a The establishment of an access requires 
attempts and preparation for the surgical procedure 
that may take weeks or even months before the actual 
cannulation process.2 In emergencies, a temporary 
central venous catheter (CVC) allows rapid access for 
HD.3,a However, it has higher risk of complications 
such as infection and thrombosis.1,10,13 In addition, 
temporary CVC provides a lower blood fl ow rate,11 
thus limiting the effectiveness of HD.a
RESUMO
OBJETIVO: Analisar fatores associados à provisão de acesso vascular 
arteriovenoso no Brasil.
MÉTODOS: Estudo transversal, nacionalmente representativo, com pacientes 
com doença renal crônica terminal acompanhados em serviços de diálise ou em 
centros transplantadores no ano de 2007. A amostra incluiu apenas pacientes 
que tiveram a hemodiálise como primeira modalidade de tratamento e que 
sabiam com que tipo de acesso vascular haviam iniciado o tratamento (N 
= 2.276). Os dados são oriundos do Projeto TRS – “Avaliação econômico-
epidemiológica das modalidades de Terapia Renal Substitutiva no Brasil”. 
Regressão logística múltipla foi utilizada .
RESULTADOS: Aproximadamente 30% dos pacientes tinham acesso 
vascular arteriovenoso. Os fatores associados à baixa probabilidade de ter 
acesso vascular arteriovenoso como primeiro tipo de acesso foram: tempo de 
diagnóstico de doença renal crônica anterior à entrada em hemodiálise ≤ 1 ano, 
menor tempo de tratamento dialítico, não possuir cobertura de plano de saúde, 
residir na região Centro-Oeste, Nordeste e Sudeste, e residir na região Norte 
e ao mesmo tempo não possuir cobertura de plano de saúde. No modelo fi nal 
não foi observada associação do desfecho com variáveis socioeconômicas e 
comorbidades, mas sim com cuidados pré-diálise.
CONCLUSÕES: Os resultados mostram que, para aumentar a provisão de 
acesso vascular arteriovenoso antes do início da hemodiálise no Brasil, os 
esforços devem ser focados no cuidado pré-diálise.
DESCRITORES: Fístula Arteriovenosa. Acesso aos Serviços de Saúde. 
Diálise Renal, instrumentação. Insufi ciência Renal Crônica. Estudos 
Transversais.
INTRODUCTION
a National Kidney Foundation. 2006 Updates clinical practice guidelines and recommendations. New York;2006 [cited 2009 Aug]. Available 
from: http://www.kidney.org/professionals/kdoqi/pdf/12-50-0210_JAG_DCP_Guidelines-VA_Oct06_SectionC_ofC.pdf
b Ministério da Saúde. Portaria nº 432 de 6 de junho de 2006. [cited 2009 Oct]. Diario Ofi cial Uniao. 7 jun 2006; Seção 1.
In Brazil dialysis centers of the Sistema Único de Saúde 
(SUS – National Public Health System) have a protocol 
of establishing an arteriovenous vascular access as early 
care.b However, according to data from the Brazilian 
Society of Nephrology in 2008, 66% of the patients who 
started HD using catheters had their treatment started 
without previous preparation by health providers. And 
patients later referred to a nephrologist are also likely 
to start dialysis using a temporary catheter.19 There 
has been no national study to assess factors associated 
with the establishment of permanent vascular access 
in Brazil. This study aimed to assess factors associated 
with this procedure in ESRD patients.
METHODS
The present study is part of a large cross-sectional 
study, the “TRS Project – Economic and Epidemiologic 
Evaluation of Modalities of Renal Replacement 
Therapy in Brazil,” conducted by the Universidade 
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Federal de Minas Gerais Health Economics Research 
Group from January to May 2007.
Patients were recruited from 81 dialysis and 17 trans-
plant centers accredited by the Brazilian Nephrology 
Society whose main databases were available to the 
public health sector. The sample was representative 
of the national Brazilian population. A total of 3,036 
patients who had undergone renal replacement therapy 
were interviewed using structured questionnaires by 
previously trained interviewers. Information on socio-
economic and demographic characteristics as well as 
on quality of life was collected. The patients’ satisfac-
tion level was also assessed. All patients selected were 
18 years old or more diagnosed with ESRD and were 
either on dialysis for at least three months or were 
at least six months post-kidney transplant. Patients 
who had multiple transplants were excluded from the 
study. A stratifi ed two-stage cluster sample was applied 
and sampling units were: renal replacement therapy 
services and patients. Only patients who had HD as 
a primary dialysis modality were enrolled (2,276 
subjects) in the present study. The statistical power 
of the sample was 99.9%.
Hypothesis testing to compare proportions and error 
probability was applied to verify the sample power 
before the study. The prevalence of arteriovenous 
fi stula used in this formula was described in interna-
tional studies.14
The response variable was the primary type of vascular 
access used for hemodialysis in each patient (arteriove-
nous vascular access including arteriovenous fi stula and 
arteriovenous graft; or temporary CVC). The explana-
tory variables included age, gender, income, education 
level, skin color, city, region of residence, private health 
insurance coverage and clinical variables (time of HD 
start since the diagnosis of chronic renal failure [CRF] 
and presence of diabetes mellitus and hypertension 
before HD). All variables with “do not know” answers 
were considered as having “missing” information.
The descriptive analysis included measure of frequency 
distribution and central tendency. The association 
between response and explanatory variables was 
assessed by univariate logistic regression and those vari-
ables with p ≤ 0.20 were included in the multiple model. 
The odds ratio (OR) was used to assess power analysis 
and its related 95% confi dence interval (95% CI).
The relevance of each variable included in the multiple 
model was verifi ed by the Wald test, and those variable 
with no signifi cant contribution were removed. The 
adjustment of the fi nal model was verifi ed by comparing 
it with other similar models through the likelihood-ratio 
test, as well as by the Hosmer-Lemeshow goodness-
of-fi t test. The fi nal model included variables with p ≤ 
0.05. The interaction between the variables in the fi nal 
model was also tested. Thus, based on the algorithm, the 
probability of occurrence was estimated. The analyses 
were performed using the software R version 2.7.2.
The study was approved by the Research Ethics 
Committee of the Universidade Federal de Minas 
Gerais in 2004 (ETIC 0397/04). All subjects and renal 
replacement therapy centers were asked to sign a 
consent form prior to their participation in the study.
RESULTS
Among the 2,276 patients studied, 1,466 were on 
HD therapy at the time of the interview, 351 were on 
peritoneal dialysis and 459 had kidney transplantation. 
Their mean age was 49 years (SD = 14.4). The average 
monthly income, reported by 2,205 patients, was US$ 
400.5 (SD = US$ 680.9), approximately 2.4 times the 
monthly minimum wage in Brazil at the time. The mean 
duration of dialysis therapy reported by 2,173 patients 
was 4.88 years (SD = 4.47) (Table 1).
Of the patients studied, 31% had arteriovenous vascular 
access for HD as a primary access, while 69% had 
temporary CVC. The univariate analysis showed lower 
rates of permanent vascular access associated with 
younger age; education level ≤ 11 years; low income; 
dark skin color; living in capital cities; and living in any 
region other than southern Brazil. Having no private 
health insurance, absence of diabetes or hypertension 
before diagnosis, time of HD start since the diagnosis 
of CRF ≤ 1 year and shorter dialysis therapy were also 
associated factors (Table 2).
Four factors were associated with low establishment 
of permanent vascular access in the multiple logistic 
regression: time of HD start since the diagnosis of CRF 
≤ 1 year; shorter dialysis therapy; having no private 
health insurance; and living in the northeastern, central-
western or southeastern regions.
A multiplicative interaction between having no private 
health insurance and the region of residence was identi-
fi ed. Thus, the fi nal model included the following vari-
ables: time of HD start since the diagnosis of CRF ≤ 1 
year; shorter dialysis therapy; having no private health 
insurance; living in the northeastern, central-western or 
southeastern regions and living in the northern region 
combined with having no private health insurance 
(Table 3). The Hosmer-Lemeshow test result was 0.347.
Those patients diagnosed with CRF one year before 
starting HD were 3.4 times more likely to start therapy 
with a temporary CVC. The increment of one year of 
treatment increased the likelihood of having an arte-
riovenous vascular access. Having no private health 
insurance increased that likelihood of starting therapy 
with a temporary vascular access to almost 1.56. 
Patients living in the southeastern, central-western 
and northeastern regions were 1.6, 2.6 and 2.9 more 
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likely to use a temporary CVC as a primary access for 
HD, respectively. Those patients living in the northern 
region who did not have private health insurance were 
4.3 times more likely to start treatment with a temporary 
vascular access.
DISCUSSION
There were identifi ed fi ve socioeconomic and clinical 
factors associated with lower likelihood of arteriove-
nous vascular access as primary type of access for HD 
in Brazil: time of HD start since the diagnosis of CRF ≤ 
1 year; shorter dialysis therapy; having no private health 
insurance; living in the northeastern, central-western or 
southeastern regions; and living in the northern region 
and having no private health insurance. Stehman-Breen 
et al21 (2000) reported that 35% of the patients selected 
from dialysis centers in the US had permanent access 
at the beginning of therapy, and those who had been 
informed about their illness earlier were more likely to 
have permanent access at the beginning of HD therapy. 
This refl ects proper pre-dialysis care.4 An early diag-
nosis of chronic renal disease allows enough time to 
the patient to accept a vascular access and to prepare 
it, as well as to detect and correct any inadequacy in 
the maturation process. Pre-dialysis care includes not 
only care provided by a nephrologist, but also patient 
education by other health providers.
Although the effect of early care provided by nephrolo-
gists was not investigated in our study, Stehman-Breen 
et al21 study also showed that more visits to the nephrol-
ogist before starting HD increased the likelihood of 
establishing a permanent access prior to therapy. In 
United States, Arora et al4 (1999) and Astor et al5 
(2001) concluded that a delayed referral of patients to 
a nephrologist negatively affected the establishment of 
permanent vascular access in primary HD. This fi nding 
points out the importance of nephrologist care.
Arora et al4 (1999) also found that a substantial number 
of patients seen earlier by nephrologists still had cath-
eters at the beginning of treatment. It suggests that 
adequate preparation of patients with ESRD requires 
referral to a nephrologist at an even earlier time point 
in the course of chronic renal disease, and requires a 
Table 1. Characteristics of patients on hemodialysis as primary 
modality of renal replacement therapy. Brazil, 2007.
Variable n %
Socioeconomic and demographic
Gender
Male 1,281 56.3
Female 995 43.7
Skin colora
Black 295 12.9
White 965 42.4
Asian 71 3.1
Mixed 765 33.6
Indigenous 41 1.8
Other 113 5.0
Do not know 26 1.1
Education levela
Illiterate 137 6.0
≤ 4 years of formal education 711 31.2
≤ 8 years of formal education 615 27.0
≤ 11 years of formal education 571 25.1
> 11 years of formal education 238 10.5
Do not know 4 0.2
Private health insurancea
No 1,552 68.2
Yes 720 31.7
Do not know 4 0.2
City of residence
Capital 865 38.0
Interior 1,411 62.0
Region of residence
Southeastern 1,060 46.6
Central-western 180 7.9
Northeastern 354 15.6
Northern 114 5.0
Southern 567 24.9
Clinical conditions
Diabetesa 
Yes 538 23.7
No 1,732 76.1
Do not know 6 0.3
Hypertensiona 0.1
Yes 1,937 85
No 337 14.8
Do not know 2 0.1
Primary type of vascular accessa
Arteriovenous vascular access 704 30.9
Temporary central venous 
catheter
1,568 68.9
Do not know 4 0.2
To be continued
Table 1 continuation
Variable n %
Time before HD start since 
diagnosis of CRFa
≤ 1 year 1,387 60.9
> 1 year 730 32.1
Do not know 159 7.0
CRF: chronic renal failure; HD: hemodialysis.
a “missing” variables
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multidisciplinary team for pre-dialysis care (generalists, 
nurses and providers), not only nephrologists.
Patients with health insurance coverage were more 
likely to have an arteriovenous vascular access before 
primary HD. This fi nding may be explained by the fact 
that private health service include outpatient access7 and 
regular medical visits.12 According to Mendoza-Sassi 
& Béria,12 (2003) Brazilian patients with private insur-
ance coverage were 80% more likely to have regular 
medical attention.
Ribeiro et al17 (2006) found that SUS users seek more 
medical care in emergency services and suggested that 
these units are the fi rst to provide care to these patients. 
For patients with ESRD, it is not ideal. Ongoing care 
is necessary and should promote early referral of 
patients to establish a permanent vascular access before 
hemodialysis.
The duration of dialysis therapy was associated with 
the establishment of an arteriovenous vascular access 
in the present study. It is possible that patients starting 
Table 2. Univariate logistic regression of the use of temporary central venous catheter as primary access including other factors. 
Brazil, 2007.
Variable
Arteriovenous 
vascular access (%)
OR 95%CI p-value
Age* (years) 0.989 0.983;0.996 0.001
Gender
Male 31.1 0.986 0.824;0.180 0.877
Female 30.8
Education level*
≤ 11 years of formal education 30.1 1.712 1.301;2.255 0.000
> 11 years of formal education 42.3
Income* (US$) 1.000 1.000;1.000 0.002
Skin color*
Black 25.1 1.394 1.054;1.845 0.02
Non-black 31.8
City of residence*
Capital 28.5 1.204 1.000;1.448 0.045
Interior 32.5
Region of residence*
Southeastern 31.8 1.484 1.201;1.834 0.000
Central-western 25.6 2.017 1.387;2.934 0.000
Northeastern 16.6 3.534 2.547;4.904 0.000
Northern 27.2 1.854 1.188;2.894 0.007
Southern 40.9
Private health insurance*
No 27.1 1.761 1.461;2.123 0.000
Yes 39.4
Diabetes mellitus*
Yes 34.2 0.830 0.675;1.019 0.076
No 30
Hypertension*
Yes 31.5 0.841 0.651;1.087 0.186
No 27.9
Time before HD start since diagnosis of CRF*
≤ 1 year 21.1 3.523 2.900;4.279 0.000
> 1 year 48.3
Duration of dialysis (years) therapy* 0.950 0.932;0.969 0.000
OR: odds ratio of temporary central venous catheter vs. arteriovenous vascular access; CI: confi dence interval; CRF: chronic 
renal failure; HD: hemodialysis.
* p≤0.20 (Wald test)
246 Permanent vascular access Silva GM et al
treatment at different time points are subject to different 
care practices or have access to different services. Also, 
changes in the epidemiological profi le of patients such 
as aging, higher rates of diabetes and cardiovascular 
diseases, can occur over time and offset the improve-
ments in patient care.9
The region of residence also infl uenced the likelihood 
of establishing permanent vascular access for HD. 
One possible explanation for regional differences is 
greater concentration of medical doctors, particularly 
specialists, in certain regions. For example, 80% of 
nephrologists have their practices in the southeastern 
and southern regions.11 This discrepancy in the distribu-
tion of medical doctors may be attributed to different 
economic development of Brazilian regions and more 
availability of medical residence and better working 
and employment conditions in these regions.15
However, in the present investigation, it is not clear 
why patients from the southeastern region had less 
permanent access as compared to those in the southern 
region. Ribeiro et al17 (2006) found that patients from 
the southern region are more likely to use SUS services 
than those from southeastern Brazil.
Differences in the provision of dialysis and preparation 
of vascular access were reported throughout the UK,6 
but they could not be entirely explained based on age 
and/or ethnic groups, thereby suggesting the infl uence 
of other factors such as service capacity and/or prac-
tice standard.6 Although almost half of HD services in 
Brazil are located in the southeastern region,20 it seems 
that they are not suffi ciently effective. Travassos et 
al22 (2006) found a lower utilization of public health 
services in the northern, northeastern and central-
western than in the southeastern region.
Regional differences in the establishment of vascular 
access associated with not having private health insur-
ance can be explained by differences in the proportion 
of patients who have private health insurance within 
each region. The multiplicative interaction of the vari-
ables having no private health insurance and region 
of residence showed a better fi tting model. Patients 
living in the northern region who did not have private 
insurance were signifi cantly less likely to start HD with 
permanent vascular access. Ribeiro et al17 (2006) have 
previously reported this gap in the proportion of SUS 
users with and without private health insurance in each 
region: 21:1 and 15:1 in the northeastern and northern 
regions, respectively.
The present study has some limitations. First, its cross-
sectional design does not allow any causal inference. 
The fi ndings should be interpreted as associations 
since exposure and outcome occurred simultaneously. 
A prevalence bias may have occurred due to selection 
into or out of the study population: patients who were 
not successful in getting primary permanent vascular 
access or died before HD start were less likely to 
participate in the study. In addition, the variables were 
self-reported and thus subject to recall bias. However, 
the dichotomization of the variables skin color and 
time of HD start since the diagnosis and the inclusion 
of duration of dialysis therapy may have reduced the 
chance of error. Other important variables such as time 
of referral to a nephrologist and potential problems 
while establishing an arteriovenous vascular access 
were not investigated.
Variables usually associated with permanent vascular 
access,1,16 such as dark skin color, age, income, educa-
tion level and presence of comorbidities including 
Table 3. Logistic regression, including interaction, associating use of temporary central venous catheter as primary access to 
predictor variables. Brazil, 2007.
Factor OR 95%CI 
Time before HD start since diagnosis of CRF ≤ 1 year* 3.432 2.804;4.208
Duration of dialysis therapy* 0.940 0.929;0.962
Having no private health insurance* 1.555 1.052;2.302
Region of residence 
Southeastern* 1.543 1.037;2.999
Central-Western* 2.593 1.340;5.206
Northeastern* 2.864 1.607;5.225
Northern* 0.725 0.361;1.463
Living in the Southeastern region x having no private health insurance 0.893 0.546;1.458
Living in the Central-western region x having no private health insurance 0.604 0.259;1.389
Living in the Northeastern region x having no private health insurance 1.162 0.549;2.447
Living in the Northern region x having no private health insurance* 4.293 1.535;12.854
OR: odds ratio of temporary central venous catheter vs. arteriovenous vascular access; CI: confi dence interval; CRF: chronic 
renal failure; HD: hemodialysis.
* p≤0.05 (t-test for coeffi cients)
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diabetes mellitus and hypertension, were not statisti-
cally signifi cant in the multiple analysis. In the fi nal 
model, the factors associated with failure to establish 
an arteriovenous vascular access for all ESRD patients 
were mainly related to pre-dialysis care. Therefore, 
given the increasing number of patients on HD in 
Brazil,20 it is important to implement a care program to 
ESRD patients that includes establishing an adequate 
arteriovenous access prior to HD, which in turn may 
be cost-effective and ultimately improve these patients’ 
quality of life.18,23 Further investigations are needed 
to explore the characteristics of dialysis services that 
may influence establishing a permanent vascular 
access for HD.
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